List of Integrated DNA Technologies Executive and Leadership Team

Leadership Overview

Integrated DNA Technologies has 5 executives leading key functions including strategy, technology, finance, and operations.

Driven by innovation, Integrated DNA Technologies is dedicated to advancing life sciences through custom nucleic acid solutions, impacting academic research, clinical diagnostics, and pharmaceutical development globally.

Leadership Roles at Integrated DNA Technologies

Chief Executive Officer - Maz Mohadjer

Group Chief Executive Officer - Alfonso Avila

Chief Financial Officer - Alan M

President At IDT, A Danaher Company - Ajay Gannerkote

Chief Technology Officer - Chuen-Der Lien

Maz Mohadjer - Chief Executive Officer

Maz Mohadjer, the Chief Executive Officer at Integrated DNA Technologies, directs the company's overarching strategy and operational execution. Overseeing all business units, Mohadjer ensures alignment with the mission to supply custom nucleic acids for academic research, biotechnology, clinical diagnostics, and pharmaceutical development. This leadership role involves driving market expansion and fostering innovation within the life sciences sector. By optimizing resource allocation and strategic partnerships, Maz Mohadjer strengthens the company's position as a premier provider of nucleic acid products. The Chief Executive Officer's focus remains on sustainable growth and enhancing the company's impact on scientific advancement.

Alfonso Avila - Group Chief Executive Officer

Alfonso Avila, the Group Chief Executive Officer at Integrated DNA Technologies, guides the strategic direction and performance across the organization. Avila's responsibilities encompass ensuring robust operational frameworks and driving long-term value creation for stakeholders. This executive leadership position involves cultivating a culture of excellence and accountability throughout the company's global operations. By focusing on market dynamics and emerging opportunities, Alfonso Avila positions Integrated DNA Technologies for continued leadership in the life sciences industry. The Group Chief Executive Officer's mandate includes overseeing strategic initiatives that enhance the company's competitive advantage and expand its reach in critical research and diagnostic markets.

Alan M - Chief Financial Officer

Alan M, the Chief Financial Officer at Integrated DNA Technologies, directs all financial operations and strategic fiscal planning. Overseeing budgeting, forecasting, and financial reporting, M ensures the company's fiscal health and supports sustainable growth initiatives. This executive function involves managing capital allocation, optimizing financial performance, and mitigating financial risks across the organization. By providing critical financial insights, Alan M enables informed decision-making to advance the company's objectives in supplying custom nucleic acids for research and diagnostics. The Chief Financial Officer's strategic guidance is essential for maintaining financial stability and driving profitability in the competitive life sciences market.

Ajay Gannerkote - President At IDT, A Danaher Company

Ajay Gannerkote, the President At IDT, A Danaher Company at Integrated DNA Technologies, leads strategic operations and business development initiatives. Gannerkote's purview includes driving operational excellence and market penetration for custom nucleic acid products across academic, diagnostic, and pharmaceutical sectors. This leadership position involves fostering cross-functional collaboration and ensuring seamless integration within the broader Danaher Company framework. By focusing on innovation and customer-centric solutions, Ajay Gannerkote enhances Integrated DNA Technologies' global impact and market leadership. The President's strategic oversight is crucial for achieving growth targets and advancing the company's mission in the life sciences industry.

Chuen-Der Lien - Chief Technology Officer

Chuen-Der Lien, the Chief Technology Officer at Integrated DNA Technologies, architects the company's technological vision and innovation pipeline. Overseeing research and development, Lien drives the creation and enhancement of custom nucleic acid products that serve academic research, biotechnology, and pharmaceutical development. This critical role involves managing the technological infrastructure and ensuring cutting-edge solutions meet evolving market demands. By championing scientific exploration and advanced manufacturing techniques, Chuen-Der Lien ensures Integrated DNA Technologies remains at the forefront of the life sciences industry. The Chief Technology Officer's efforts directly support the development of novel applications in clinical diagnostics and therapeutic discovery.

Explore Leadership Teams in Manufacturing

Columbia Care

Columbia Care is a multi-state medical cannabis cultivator, manufacturer and provider of cannabis products and related services. Columbia Care is headquartered in New York, New York.

Company Leadership

Merz Aesthetics

Merz North America Inc is a company that operates in the Pharmaceuticals industry. It employs 1000to4999 people and has 500Mto1G of revenue. The company is headquartered in Raleigh, North Carolina.

Company Leadership

Torrent Pharma

Torrent Pharmaceuticals Ltd is the flagship enterprise of the Torrent Group and stands among the leading pharmaceutical companies in India, with a strong and growing international presence. The company is widely recognized for its leadership across key therapeutic areas, including cardiovascular health, central nervous system disorders, gastro-intestinal care, vitamins, minerals and nutritionals, and cosmo-dermatology, while also maintaining a meaningful footprint in diabetology, pain management, gynaecology, oncology and anti-infective treatments. Built on a foundation of scientific excellence and innovation, Torrent Pharma places research and development at the core of its strategy, supported by advanced infrastructure and a highly skilled scientific workforce dedicated to developing high-quality, affordable medicines for patients worldwide.

Company Leadership

Organon

Organon creates, manufactures and markets innovative prescription medicines that improve the health and quality of human life. Through a combination of innovation and business partnerships, Organon seeks to leverage each of its core therapeutic fields.

Company Leadership

Frequently Asked Questions Regarding Integrated DNA Technologies Top Executives and Leadership Team

Who leads Integrated DNA Technologies?

Integrated DNA Technologies is led by Maz Mohadjer (Chief Executive Officer), along with executives such as Alfonso Avila (Group Chief Executive Officer) and Alan M (Chief Financial Officer).

Who is part of Integrated DNA Technologies’s executive team?

The executive team of Integrated DNA Technologies includes leaders such as Maz Mohadjer (Chief Executive Officer), Alfonso Avila (Group Chief Executive Officer), Alan M (Chief Financial Officer) and other senior executives.

How many executives does Integrated DNA Technologies have?

Integrated DNA Technologies has 5 executives leading key business areas.

What roles are included in Integrated DNA Technologies’s leadership team?

The leadership team of Integrated DNA Technologies includes roles such as Chief Executive Officer, Group Chief Executive Officer, Chief Financial Officer, President At IDT, A Danaher Company, Chief Technology Officer.